4//SEC Filing
Telman Deborah H 4
Accession 0001127602-25-019654
CIK 0000882095other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 5:10 PM ET
Size
12.0 KB
Accession
0001127602-25-019654
Insider Transaction Report
Form 4
Telman Deborah H
EVP, Corporate Affairs & GC
Transactions
- Tax Payment
Common Stock
2025-07-25$116.20/sh−3,823$444,233→ 42,721 total - Exercise/Conversion
Common Stock
2025-07-25+514→ 38,315 total - Exercise/Conversion
Restricted Stock Unit
2025-07-25−514→ 29,875 total→ Common Stock (514 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-07-25−8,229→ 21,646 total→ Common Stock (8,229 underlying) - Exercise/Conversion
Common Stock
2025-07-25+8,229→ 46,544 total
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- [F3]The restricted stock units have a three-year vesting schedule. 33.33% will vest on each yearly anniversary of the date of the grant until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001860008
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 5:10 PM ET
- Size
- 12.0 KB